SEPTInvestingStart Free

SION 10-Q: SEC filing

Sionna Therapeutics

Filed with the SEC on · accession 0001628280-26-072499

SION filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.

Summary of the filing

Sionna Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing a restructuring event dated September 9, 2026 involving employee severance and contract termination costs.

For details, click here →How to read a 10-Q →

Key details

FilerSionna Therapeutics, Inc.

✦ Ask GOAX AI about this filing — what it means for SION, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SION?

Click here

Frequently asked questions

What did SION file with the SEC on Nov 10, 2026?

SION filed a 10-Q (SEC filing). Sionna Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing a restructuring event dated September 9, 2026 involving employee severance and contract termination costs.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other SION SEC filings

Get alerts when SION files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
SION overviewSION analysisSION newsLatest SEC filings